Logo wahanariau.com
  2. New jersey

New jersey

Index
Globenewswire

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Senin, 30 Maret 2026 - 22:26:49 Wib
Globenewswire

BHAV Acquisition Corp Announces Closing of $100 Million Initial Public Offering

Senin, 23 Maret 2026 - 04:23:31 Wib
Globenewswire

BHAV Acquisition Corp Announces Pricing of $100 Million Initial Public Offering

Jumat, 20 Maret 2026 - 04:16:25 Wib
Globenewswire

Checkmarx Redefines Application Security for the Age of Agentic Development

Selasa, 17 Maret 2026 - 04:38:11 Wib
Globenewswire

Jelly Toast Diluncurkan di India untuk Memudahkan Perayaan Sehari-hari

Rabu, 04 Maret 2026 - 23:12:24 Wib
Globenewswire

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Rabu, 04 Maret 2026 - 05:40:38 Wib
Globenewswire

Jelly Toast Launches in India to Simplify Everyday Celebrations

Rabu, 04 Maret 2026 - 05:25:49 Wib
Globenewswire

Telkomsel Memperluas Implementasi Capsyl Cloud bersama Synchronoss

Rabu, 04 Maret 2026 - 05:17:32 Wib
Globenewswire

Telkomsel Expands Capsyl Cloud Deployment with Synchronoss

Selasa, 03 Maret 2026 - 05:04:03 Wib
Globenewswire

Teva to Present at the Upcoming Investor Conferences in March

Rabu, 25 Februari 2026 - 06:28:43 Wib
Globenewswire

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Senin, 23 Februari 2026 - 11:54:59 Wib
Globenewswire

Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

Kamis, 19 Februari 2026 - 20:10:05 Wib
Globenewswire

Verisk Names Steven Kauderer President of Claims Solutions

Selasa, 10 Februari 2026 - 05:55:01 Wib
Globenewswire

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Jumat, 30 Januari 2026 - 20:03:30 Wib
Globenewswire

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

Selasa, 27 Januari 2026 - 22:09:08 Wib
Globenewswire

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

Kamis, 15 Januari 2026 - 20:12:04 Wib
Globenewswire

Impulse Dynamics® Announces New Chief Financial Officer

Rabu, 14 Januari 2026 - 05:20:48 Wib
Globenewswire

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Selasa, 13 Januari 2026 - 05:45:26 Wib
Globenewswire

Synchronoss Memamerkan Perluasan Platform Personal Cloud, Momentum Capsyl, dan Menampilkan Pratinjau Penawaran Baru di CES 2026

Rabu, 07 Januari 2026 - 19:01:22 Wib
Globenewswire

Synchronoss Showcases Expanded Personal Cloud Platform, Capsyl Momentum, and Previews New Offering at CES 2026

Rabu, 07 Januari 2026 - 05:53:45 Wib
Globenewswire

Verisk Ends Effort to Acquire AccuLynx

Senin, 29 Desember 2025 - 23:41:21 Wib
Globenewswire

DALI Alliance Meluncurkan Spesifikasi Pengujian dan Sertifikasi untuk Gateway Nirkabel ke DALI

Selasa, 23 Desember 2025 - 21:29:23 Wib
Globenewswire

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways

Senin, 22 Desember 2025 - 21:22:22 Wib
Globenewswire

Impulse Dynamics Completes $158M Financing Round

Kamis, 11 Desember 2025 - 01:16:43 Wib
Globenewswire

Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Kamis, 11 Desember 2025 - 00:07:40 Wib